What the near Future Holds for Sacubitril/Valsartan: A Summary of Major Ongoing Studies

Early research on neprilysin inhibition showed that sacubitril/valsartan, a combination of the valsartan and the neprilysin inhibitor sacubitril, was superior to enalapril in patients with heart failure with reduced ejection fraction (HFrEF) in the PARADIGM-HF study in 2014. Therefore, for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Badreldin, Hisham A., Aldosari, Nasser, Alnashwan, Lama, Almutairi, Taif, Yousif, Nada, Alsulaiman, Khalid, Aljuhani, Ohoud, Hafiz, Awatif, Alshaya, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875386/
https://www.ncbi.nlm.nih.gov/pubmed/35200707
http://dx.doi.org/10.3390/jcdd9020054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875386/
https://www.ncbi.nlm.nih.gov/pubmed/35200707
http://dx.doi.org/10.3390/jcdd9020054

Ejemplares similares